Early-stage VC since 1987 backing seed/Series A technology and healthcare companies; $6.8B AUM.
VCEarly-stage📍 Menlo Park, CAFounded 1987
AUM
$6.8B
as of 2023-Q2
MID
Canaan is an early-stage venture firm founded in 1987 that partners with founders from seed and Series A across technology (enterprise, consumer, frontier tech, fintech) and healthcare, including company creation in therapeutics. In April 2023 it closed the oversubscribed $650M Canaan XIII plus $200M of additional commitments, bringing AUM to $6.8B. Cited exits include Dexcom, Instacart, Match, TheRealReal, Day One Biopharmaceuticals, Arvinas and Kustomer.
Firm Profile
Firm Type
VC
Subtype
Early-stage
Founded
1987
HQ
Menlo Park, CA
Country
USA
Active Fund
Canaan XIII ($650M) · 2023
Notable Partners
Maha IbrahimTim ShannonJohn PacificoNina Kjellson
Portfolio Companies (8)
World ViewInstacartDexcomMatchTheRealRealDay One BiopharmaceuticalsArvinassnyk
Investment Focus
Stages
Seed · Series A
Sectors
Enterprise · Healthcare · Bio · Consumer · Deep Tech
VCEarly-stageSJ Top 100
Investor data reflects publicly disclosed AUM, fund sizes, and portfolio holdings as of 2023-Q2. Refreshed periodically.